July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Central retinal thickness is the principal determinant of visual function in retinal vein occlusion
Author Affiliations & Notes
  • Martin Michl
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Vienna, Austria
  • Xuhui Liu
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Vienna, Austria
  • Alexandra Kaider
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Vienna, Austria
  • Amir Sadeghipour
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Vienna, Austria
  • Bianca S Gerendas
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Vienna, Austria
  • Ursula Schmidt-Erfurth
    Department of Ophthalmology and Optometry, Medical University of Vienna, Vienna, Vienna, Austria
  • Footnotes
    Commercial Relationships   Martin Michl, None; Xuhui Liu, None; Alexandra Kaider, None; Amir Sadeghipour, None; Bianca S Gerendas, None; Ursula Schmidt-Erfurth, Böhringer-Ingelheim (C), Genentech (C), Novartis (C), Roche (C)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1711. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Martin Michl, Xuhui Liu, Alexandra Kaider, Amir Sadeghipour, Bianca S Gerendas, Ursula Schmidt-Erfurth; Central retinal thickness is the principal determinant of visual function in retinal vein occlusion. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1711.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : In retinal vein occlusion (RVO), optical coherence tomography (OCT) is the main diagnostic tool to detect morphological changes of the retina and assess disease progression and treatment response. The purpose of this study was to determine the impact of retinal changes seen in baseline OCT images and demographic factors on visual acuity (BCVA) in untreated RVO patients.

Methods : Posthoc analysis including OCT data of treatment-naïve BRVO and CRVO patients from the Vienna Reading Center imaging database. Key inclusion criteria were a BCVA letter score between 73 and 19 ETDRS letters and age>18 years. Primary outcome measure was the mean change in ETDRS letters associated with each individual biomarker, indicated by its regression coefficient. The latter was obtained by calculating multivariable regression models, using the backward method for variable selection. Morphological changes covered central retinal thickness (CRT), foveal contour, intra- and subretinal fluid (IRC,SRF), ELM/EZ integrity, disorganization of retinal inner layers, hyperreflective foci (HRF), conditions of vitreomacular interface and signs of ischemia. Demographic factors included age, disease duration and gender. Morphological grading was done manually by a masked and certified grader as well as retina expert of the reading center.

Results : Included were 381/301 patients with BRVO/CRVO, in which the following biomarkers were statistically significant: in BRVO, 100µm increase in CRT at the central subfield (CSF)/100µm increase in cyst height/IRC at center point (CP) correlated with a change in ETDRS letters of -8.7,-1.0,+2.4. In CRVO, 100µm increase in CRT at CSF/presence of IRC at the CP was associated with a loss of -9.7 and -4.5 letters. In the total cohort, 100µm increase in CRT at CSF/30HRF on the central B-scan/SRF at CP correlated with a change of -9.0,-1.9 and +2.5 letters. Letter changes due to age/female gender/doubling of disease duration were -2.5/-3.4/NI (not included) for BRVO, -1.3/NI/-0.8 for CRVO, and -2.0/-2.5/NI for the total cohort. Adjusted multiple R-squared for the respective model was 19.8%/28.4%/25.4%.

Conclusions : Structurally, an increase in CRT and the presence of IRC/SRF on baseline OCT images correlate most with vision in RVO patients at the treatment-naïve stage. Reviewing OCT images for the presence of fluid is therefore critical in the monitoring and treatment of RVO patients.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×